InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Thursday, 04/18/2019 9:42:01 AM

Thursday, April 18, 2019 9:42:01 AM

Post# of 8022
Welcome @Briefingcom Followers!
twitter
$VCEL: Correction: Vericel did not appoint new CEO and original post has been removed (16.26)
Obsidian Therapeutics, a biotechnology company developing cell-based therapeutics with controllable operating systems, today announced the appointment of Paul K. Wotton, Ph.D., as Chief Executive Officer. He succeeds Michael Gilman, Ph.D., who will focus on Arrakis Therapeutics and continue to serve on Obsidian's Board of Directors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News